HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Intravenous immunoglobulins (human immunoglobulins G)

TERMINATED · PHASE3 · ANCA + Vasculitides Relapsing Either Under Corticosteroid, and Immunosuppressant Therapies or After One Year, Post Treatment.

Unknown stopping reason

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.